Caspofungin for the Treatment of Non-blood Candida Infections (0991-045)

NCT00083343 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Candidiasis

Interventions

DRUG: MK0991, caspofungin acetate/Duration of Treatment: variable

Sponsor

Merck Sharp & Dohme LLC